Financial Perspectives’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $189K | Hold |
11,251
| – | – | 0.06% | 153 |
|
|
2025
Q1 | $173K | Hold |
11,251
| – | – | 0.06% | 153 |
|
|
2024
Q4 | $248K | Hold |
11,251
| – | – | 0.08% | 125 |
|
|
2024
Q3 | $203K | Hold |
11,251
| – | – | 0.07% | 138 |
|
|
2024
Q2 | $183K | Hold |
11,251
| – | – | 0.07% | 143 |
|
|
2024
Q1 | $159K | Hold |
11,251
| – | – | 0.06% | 159 |
|
|
2023
Q4 | $117K | Hold |
11,251
| – | – | 0.05% | 181 |
|
|
2023
Q3 | $115K | Hold |
11,251
| – | – | 0.05% | 170 |
|
|
2023
Q2 | $84.7K | Hold |
11,251
| – | – | 0.04% | 209 |
|
|
2023
Q1 | $99.6K | Hold |
11,251
| – | – | 0.05% | 184 |
|
|
2022
Q4 | $103K | Sell |
11,251
-305
| -3% | -$2.78K | 0.05% | 173 |
|
|
2022
Q3 | $93.3K | Hold |
11,556
| – | – | 0.05% | 176 |
|
|
2022
Q2 | $86.9K | Hold |
11,556
| – | – | 0.05% | 182 |
|
|
2022
Q1 | $109K | Hold |
11,556
| – | – | 0.05% | 182 |
|
|
2021
Q4 | $92.6K | Sell |
11,556
-2,891
| -20% | -$23.2K | 0.04% | 182 |
|
|
2021
Q3 | $141K | Buy |
14,447
+10,526
| +268% | +$103K | 0.07% | 146 |
|
|
2021
Q2 | $38.8K | Sell |
3,921
-16,043
| -80% | -$159K | 0.02% | 285 |
|
|
2021
Q1 | $1.73M | Buy |
19,964
+19,620
| +5,703% | +$1.7M | 0.09% | 154 |
|
|
2020
Q4 | $3.32K | Buy |
344
+39
| +13% | +$376 | ﹤0.01% | 511 |
|
|
2020
Q3 | $2.75K | Hold |
305
| – | – | ﹤0.01% | 471 |
|
|
2020
Q2 | $3.76K | Hold |
305
| – | – | ﹤0.01% | 435 |
|
|
2020
Q1 | $2.74K | Hold |
305
| – | – | ﹤0.01% | 434 |
|
|
2019
Q4 | $2.99K | Buy |
+305
| New | +$2.99K | ﹤0.01% | 426 |
|